<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>advanced drug delivery technologies &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/advanced-drug-delivery-technologies/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Tue, 07 Oct 2025 10:40:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>advanced drug delivery technologies &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Advancing Long-Lasting Liraglutide Delivery with Nanolipid Clusters</title>
		<link>https://scienmag.com/advancing-long-lasting-liraglutide-delivery-with-nanolipid-clusters/</link>
		
		<dc:creator><![CDATA[Ophelia Keating]]></dc:creator>
		<pubDate>Tue, 07 Oct 2025 10:40:29 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[advanced drug delivery technologies]]></category>
		<category><![CDATA[bioresponsive nanocarriers]]></category>
		<category><![CDATA[in vitro evaluation of nanolipid systems]]></category>
		<category><![CDATA[in vivo studies on liraglutide]]></category>
		<category><![CDATA[injectable peptide therapy optimization]]></category>
		<category><![CDATA[innovative delivery systems for peptides]]></category>
		<category><![CDATA[long-acting liraglutide therapy]]></category>
		<category><![CDATA[nanolipid clusters for drug delivery]]></category>
		<category><![CDATA[nanotechnology in pharmaceuticals]]></category>
		<category><![CDATA[optimization of lipid-based drug carriers]]></category>
		<category><![CDATA[sustained release peptide formulations]]></category>
		<category><![CDATA[therapeutic applications of liraglutide]]></category>
		<guid isPermaLink="false">https://scienmag.com/advancing-long-lasting-liraglutide-delivery-with-nanolipid-clusters/</guid>

					<description><![CDATA[Jeon, SW., Lee, JJ., Sauraj et al. Optimization of injectable bioresponsive nanolipid clusters for long-acting peptide therapy with liraglutide: in vitro and in vivo evaluation. J. Pharm. Investig. (2025). https://doi.org/10.1007/s40005-025-00769-z]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" src="https://scienmag.com/wp-content/uploads/2025/10/Advancing-Long-Lasting-Liraglutide-Delivery-with-Nanolipid-Clusters.png" /></p>
<p class="c-bibliographic-information__citation">Jeon, SW., Lee, JJ., Sauraj <i>et al.</i> Optimization of injectable bioresponsive nanolipid clusters for long-acting peptide therapy with liraglutide: in vitro and in vivo evaluation.<br />
                    <i>J. Pharm. Investig.</i>  (2025). https://doi.org/10.1007/s40005-025-00769-z</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">86960</post-id>	</item>
	</channel>
</rss>
